§ 9792.27.20. Pharmacy and Therapeutics Committee -- Conflict of Interest.
8 CA ADC § 9792.27.20Barclays Official California Code of Regulations
8 CCR § 9792.27.20
§ 9792.27.20. Pharmacy and Therapeutics Committee -- Conflict of Interest.
(a) The conflict of interest standards are intended to ensure that the members of the P&T Committee are free from financial interests or other relationships that could compromise the objectivity of the members of the committee as they perform their duties to consult with the Administrative Director on formulary updates based upon the principles of evidence-based medicine. Appointed members of the P&T Committee must impartially perform formulary update review activities, and must be free of conflicts of interest.
(b) Persons applying to be appointed to the P&T Committee shall not be employed by a pharmaceutical manufacturer, a pharmacy benefits management company, or a company engaged in the development of a pharmaceutical formulary for commercial sale, and shall not have been so employed for 12 months prior to the appointment. A P&T Committee member who undertakes such employment during the term of appointment shall not be eligible to continue to serve on the committee.
(1) “Pharmaceutical entity” means a pharmaceutical manufacturer, pharmaceutical repackager, pharmaceutical relabeler, compounding pharmacy, pharmacy benefits management company, biotechnology company, or any other business entity that is involved in manufacturing, packaging, selling or distribution of prescription or non-prescription drugs, drug delivery systems, or biological agents.
Credits
Note: Authority cited: Sections 133, 4603.5, 5307.3 and 5307.27, Labor Code. Reference: Sections 4600, 4604.5, 5307.27 and 5307.29, Labor Code.
History
1. New section filed 12-7-2017; operative 1-1-2018 pursuant to Government Code section 11343.4(b)(3) (Register 2017, No. 49).
This database is current through 8/30/24 Register 2024, No. 35.
Cal. Admin. Code tit. 8, § 9792.27.20, 8 CA ADC § 9792.27.20
End of Document |